Immunomodulatory effects of cinobufagin isolated from Chan Su on activation and cytokines secretion of immunocyte in vitro

Journal of Asian Natural Products Research

Volumn 13, Issue 5, 2011, Pages 383-392

  Wang, Xiao Liang ^a   Zhao, Guang Hou ^a   Zhang, Jin ^a   Shi, Qi Yun ^a   Guo, Wei Xiao ^a   Tian, Xiu Li ^a   Qiu, Jia Zhang ^a   Yin, Li Zi ^a   Deng, Xu Ming ^a   Song, Yu ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

cinobufagin; cytokines; immunoenhancement

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHAN SU; CHINESE DRUG; CINOBUFAGIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE S PHASE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG ISOLATION; DRUG STRUCTURE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

AMPHIBIAN VENOMS; ANIMALS; BUFANOLIDES; CYTOKINES; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; MACROPHAGES, PERITONEAL; MOLECULAR STRUCTURE; SPLEEN; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957861959     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2011.565746     Document Type: Article

References (22)

1. G.M. Cragg, D.J. Newman, and K.M. Snader, J. Nat. Prod. 60, 52 (1997).
2. Y.G. Cao, Y. Song, N. An, S. Zeng, D.C. Wang, L. Yu, T.F. Zhu, T.D. Zhang, J. Cui, C.F. Zhou, and X.M. Deng, Fund. Clin. Pharmacol. 23, 457 (2009).
3. K.K. Chen and A. Kovarikova, J. Pharm. Sci. 56, 1535 (1967).
4. J.Y. Yeh, W.J. Huang, S.F. Kan, and P.S. Wang, Prostate 54, 112 (2003).
5. L. Wang, J. Wu, M. Li, X.W. Yang, and J.R. Cui, Chin. J. Oncol. 27, 717 (2005).
6. G. Amit, K. Anamika, and S. Jaswant, Int. Immunopharmacol. 6, 1543 (2006).
7. E. Benjamini, R. Coico, and G. Sunshine, Immunology: A Short Course, 4th ed. (Wiley, New York, 2000).
8. N.S. Kang, S.Y. Park, K.R. Lee, S.M. Lee, B.G. Lee, and D.H. Shin, J. Ethnopharmacol. 79, 89 (2002).
9. A. Dhur, P. Galan, P. Preziosi, and S. Hercberg, J. Nutr. 121, 1418 (1991).
10. J. Eva, S. Rosa, V. Angeles, H.L. Carmen, A.G. Zapata, and V. Alberto, J. Immunol. 168, 5005 (2002).
11. D.R. Lucey, M. Clerici, and G.M. Shearer, Clin. Microbiol. Rev. 9, 532 (1996).
12. P.H. Van der Meide and H. Schellekens, Biotherapy 8, 243 (1996).
13. P. Factor, Mol. Ther. 7, 148 (2003).
14. F. Malik, J. Singh, A. Khajuria, K.A. Suri, N.K. Satti, S. Singh, M.K. Kaul, A. Kumar, A. Bhatia, and G.N. Qazi, Life Sci. 80, 1525 (2007).
15. E. Rivera, F. Ekholm Pettersson, and M. Ingan, Vaccine 23, 5411 (2005).
16. T.H. Yang, M. Jia, J. Meng, H. Wu, and Q.B. Mei, Int. J. Biol. Macromol. 39, 179 (2006).
17. J.D. Wang, T. Narui, and S. Takatsuki, Chem. Pharm. Bull. 39, 2135 (1991).
18. Chinese Pharmacopoeia Commission,Pharmacopoeia of the People's Republic of China (Medical Publishing House, 2005), Vol. II, Appendix VI A-107.
19. J.K. Lee, M.H. Ryu, and J.A. Byun, Toxicology 210, 175 (2005).
20. N. An, D.C. Wang, T.F. Zhu, S. Zeng, Y.G. Cao, J. Cui, X.M. Deng, and Y. Song, Immunopharmacol. Immunotoxicol. 31, 451 (2009).
21. X. Shan, L. Chen, M. Cao, L. Xu, and S. Zhang, Physiol. Res. 55, 301 (2006).
22. A.C. Fluckiger, G. Marcy, and M. Marchand, Stem Cells 24, 547 (2006). 392 X.-L. Wang et al.